2017-05-11
To the editor: Venetoclax and obinutuzumab in chronic lymphocytic leukemia
Publication
Publication
Blood , Volume 129 - Issue 19 p. 2702- 2705
Additional Metadata | |
---|---|
doi.org/10.1182/blood-2017-01-761973, hdl.handle.net/1765/100107 | |
Blood | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Fischer, K., Al-Sawaf, O. (Othman), Fink, A.-M. (Anna-Maria), Dixon, M. (Mark), Bahlo, J. (Jasmin), Warburton, S. (Simon), … Hallek, M. (2017). To the editor: Venetoclax and obinutuzumab in chronic lymphocytic leukemia. Blood, 129(19), 2702–2705. doi:10.1182/blood-2017-01-761973 |